Clinical Trial Update: A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessed probucol in combination with valsartan for IgA nephropathy, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Iga Nephropathy

Drugs mentioned

• Probucol (Probucol)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Glomerulonephritis, IGA Nephropathy | Phase 4 | Status: COMPLETED